Australia
# |
Name |
Market Capitalization |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 82.91 B |
Feb. 5, 2025 | USD 169.95 | -0.56% |
|
Australia |
|
2 |
USD 311.84 M |
Jan. 31, 2025 | USD 2.09 | 0.97% |
|
Australia |
|
3 |
USD 58.91 M |
Jan. 31, 2025 | USD 4.80 | 5.03% |
|
Australia |
|
4 |
USD 29.46 M |
Jan. 31, 2025 | USD 1.67 | 2.45% |
|
Australia |
|
5 |
USD 11.64 M |
Jan. 31, 2025 | USD 2.04 | -5.56% |
|
Australia |
The Vaccines company in Australia with the highest Market Capitalization is CSL Limited (ASX: CSL.AX) at USD 82.91 B.
The Vaccines company in Australia with the lowest Market Capitalization is Immuron Limited (NasdaqCM: IMRN) at USD 11.64 M.
The top 10 Vaccines companies in Australia by Market Capitalization are CSL Limited, Immutep Limited, Alterity Therapeutics Limited, Incannex Healthcare Limited and Immuron Limited.
The bottom 10 Vaccines companies in Australia by Market Capitalization are Immuron Limited, Incannex Healthcare Limited, Alterity Therapeutics Limited, Immutep Limited and CSL Limited.